Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
11 hedge funds and large institutions have $607K invested in Genetic Technologies Ltd. in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
77% more capital invested
Capital invested by funds: $342K → $607K (+$265K)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$32.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$6.11K |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$83 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$14K |
| 2 |
Morgan Stanley
New York
|
-$1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$979 |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$246 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $354K | -$14K | -845 | -4% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $170K | +$32.5K | +1,956 | +26% |
|
|
3
Citadel Advisors
Miami,
Florida
| $29K | -$979 | -59 | -3% |
|
|
AGU
4
Alpine Group USVI
St. Thomas,
U.S. Virgin Islands
| $25K | +$23.6K | +1,422 | New |
|
5
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $15K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $10K | +$6.11K | +368 | +181% |
|
|
CG
7
Cutler Group
San Francisco,
California
| $4K | – | – | – |
|
|
RE
8
RBC Europe
London,
United Kingdom
| $71 | – | – | – |
|
|
9
Morgan Stanley
New York
| – | -$1K | -76 | Closed |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$246 | -23 | Closed |
|
|
ASN
11
Advisory Services Network
Atlanta,
Georgia
| – | +$83 | +5 | New |
|
GENE Hedge Fund Activity: Q1 2019 in Review
11 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2019, worth a combined $607K — up 77% from $342K a quarter earlier.
Fund positioning in GENE was balanced in Q1 2019: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $32.5K. The largest seller was Renaissance Technologies, cutting an estimated $14K.
- 11 institutional investors held Genetic Technologies Ltd. (GENE) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $607K of Genetic Technologies Ltd. stock for Q1 2019, up 77% quarter-over-quarter.
- 2 funds opened new Genetic Technologies Ltd. positions in Q1 2019 and 2 closed out, a net change of 0 holders.
- The largest Genetic Technologies Ltd. buyer in Q1 2019 was Susquehanna International Group, an estimated $32.5K added.
- The largest Genetic Technologies Ltd. seller in Q1 2019 was Renaissance Technologies, an estimated $14K sold.
Based on aggregated 13F filings for Q1 2019.